Tacroneph

Tacroneph Active Ingredient: Tacrolimus Available Strengths:Tacrolimus 0.25mg capsulesTacrolimus 0.50mg capsulesTacrolimus 1mg capsulesIndications & Usage: Tacrolimus is indicated for maintenance therapy as an immunosuppressive agent.Dosage & Administration: For adult kidney transplant patients, Tacrolimus is administered orally in combination with Azathioprine. The recommended initial oral dose is 0.2 mg/kg/day. Whole blood trough concentrations are observed as follows:Months 1-3: 7-20 ng/mlMonths 4-12: 5-15 ng/mlWhen used in combination with MMF/IL-2 receptor antagonist, the recommended dose is 0.1 mg/kg/day, with observed whole blood trough concentrations as follows:Months 1-12: 4-11 ng/ml.